EG 427NeurologyFrench EG 427 bags €27m in Series B fina...French targeted DNA gene therapy specialist EG427 has closed a €27m Series B financing co-led by VC investor Andera Partners and BPI France to initiate Phase I testing of a Herpes Simplex Virus 1 (nrHSV-1) … more ➔
wikipedia - AnypodetosPartnershipLindis Biotech selects Celonic Group for c...LINDIS Biotech GmbH has selected Swiss Celonic Group to manufacture its recently EU-approved malignant ascites treatment catumaxomab for commercial supply. more ➔
adobe-Stock.comCHONCHANOK PHOTOCultivated ProteinCultivated B solves fetal bovine serum pro...German-Canadian food tech specialist The Cultivated B reports that it has identified a small molecule that can replace bovine fibroblast growth factor (bFGF) in the production of cell-based meat with … more ➔
Yves Callewaert4P MedicinenaturalX secures €100m to fuel the futur...The new fund supports of NaturalX, which has its first closing at €100m, supports proactive healthcare, filling a market gap as consumers take control of their own health journey. more ➔
PX GroupBioleachingBRAIN Biotech partners with PX Group in mi...German BRAIN Biotech AG and the Switzerland’s PX Group will extend its partnership within the framework of the PX Urban Mining Initiative. The extension builds on previous work, which focused on providing … more ➔
Axplora GroupCDMOAxplora Group announces €50m expansion o...German API and antibody drug conjugate (ADC) CDMO Axplora Group GmbH has announced an investment of €50m in its Mourenx site in Southwest France, securing its position as a key player in the fight … more ➔
adobe stock - Monty RNA modalitiesEthris GmbH bags US$5m from CEPIOslo-based Coalition for Epidemic Preparedness Innovations (CEPI) has granted US$5m to RNA formulation specialis Ethris to support studies that demonstrate spray-dried RNA vaccines remain stable at … more ➔
adobe stock - pkproject TransformationThe European Alliance for the Bioeconomy w...Now that US President Donald Trump has loudly announced his intention to withdraw from the Paris climate targets and refocus the US economy on fossil fuel production, Europe, which is still a leader … more ➔
Mallia TherapeuticsHair lossMallia selects Northway to produce alopeci...Hair loss therapeutics developer Mallia Therapeutics and Northway Biotech have partners to set up a manufacturing process of soluble CD83 protein to prevent and cure hair loss. more ➔
Bild von frimufilms auf FreepikThrombo-inflammationAplagon secures €7m for APAC developmentHelsinki-based Aplagon has secured €7m in financing to advance its therapeutic APAC into Phase 2a clinical trials. more ➔